Segal Trials
Segal Trials is a privately held South Florida clinical research site network conducting Phase I–IV trials in psychiatry, neurology, addiction, women's health, infectious disease, and psychedelics for pharmaceutical sponsors and CROs across six research facilities.
- Company typePrivate
- Founded1998
- HeadquartersMiami Lakes, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Segal Trials does
Segal Trials is a privately held, founder-led clinical research site network founded in 1998 by Scott D. Segal, MD, and Bonnie Segal, headquartered in Miami Lakes, Florida. The company operates six research sites across South Florida covering Phase I through Phase IV trials in psychiatry, neurology, addiction medicine, women's health, infectious disease, general medicine, and psychedelic research. Core technical infrastructure centers on a 9,000-square-foot Early Phase unit with 29 research beds at Miami Lakes Medical Research, an inpatient Larkin Behavioral Health Services site, dedicated Women's Health, Infectious Disease, and Psychedelic & Cannabis Research centers, plus assisted-living-facility and mobile-clinic access. The business runs on contract research revenue from pharmaceutical sponsors (AbbVie, Roche, Pfizer, J&J, Janssen, Teva, Boehringer Ingelheim, Usona) and CROs (IQVIA, Syneos), with pricing negotiated per study contract. Patient recruitment is a central competency, supported by a HIPAA-compliant database of over 100,000 volunteers, dedicated retention specialists, physician referral networks, and a refer-a-friend program offering $25–$75 per qualified referral. The company is certified to GCP, ICH, FDA 21 CFR Part 11, HIPAA, and SoCRA standards, and reports contributions to 65+ FDA-approved medications and 1,500+ studies across 75+ therapeutic indications. Strategic emphasis is on CNS, psychedelic, and women's health indications, with a January 2025 strategic partnership with Cybin Inc. anchoring participation in a multinational Phase 3 program for CYB003 in Major Depressive Disorder.
Segal Trials firmographics
Firmographics- Name
- Segal Trials
- Legal name
- Segal Trials
- Website
- https://segaltrials.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Segal Trials is a privately held South Florida clinical research site network conducting Phase I–IV trials in psychiatry, neurology, addiction, women's health, infectious disease, and psychedelics for pharmaceutical sponsors and CROs across six research facilities.
- Ownership category
- akta.pro rank
Segal Trials industry classification
Industry- Product category
- Contract Clinical Research Services
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)
Keywords
Where Segal Trials is headquartered
LocationHeadquarters
- HQ city
- Miami Lakes
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Segal Trials business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Trial Services: Contract research services for pharmaceutical companies and CROs conducting Phase I-IV clinical trials. Revenue generated through study contracts for patient enrollment, data collection, and regulatory compliance services across psychiatry, neurology, addiction, general medicine, infectious diseases, psychedelics, and women's health therapeutic areas.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time | One-day outpatient studies compensation |
| Unit Pricing | One time | Outpatient study compensation |
| Unit Pricing | One time | Inpatient study compensation |
| Transaction based/ take rate | One time | Refer-a-friend program |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels10 records
Segal Trials product offering
Product offeringCore offering
Segal Trials operates a private network of clinical research sites across South Florida conducting Phase I-IV clinical trials for pharmaceutical sponsors and CROs. The company specializes in psychiatry, neurology, addiction, general medicine, infectious diseases, psychedelics research, and women's health, providing patient recruitment, data collection, quality assurance, and regulatory compliance services under contract with drug developers.
Product overview
Segal Trials is a privately held network of clinical research sites conducting Phase I-IV trials across South Florida. The company operates a platform of six research facilities offering specialized services in psychiatry/neurology, addiction, general medicine, infectious diseases, psychedelics research, and women's health. Core offerings include Miami Lakes Medical Research (inpatient and early phase studies with 29 beds), the Center for Psychedelic & Cannabis Research (first private psychedelic research facility in Florida), Women's Health & General Medicine Site, Infectious Disease Site, Larkin Behavioral Health Services, and Assisted Living Facilities research. The company provides integrated services including patient recruitment (100,000+ volunteer database), quality assurance, and regulatory compliance, having contributed to 65+ FDA-approved medications.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Trials (Phase I-IV)
- Early Phase Studies
- Psychiatric Health Research
- Addiction Research
- General Medicine Research
Quantifiable outcome
- 65+ FDA-approved medications and devices contributed to through clinical trial participation
- +4 more outcomes
Companies that use Segal Trials
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
Segal Trials technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Segal Trials partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core.
- Cybin Inc.coreStrategic partnership agreement for Cybin's multinational pivotal Phase 3 program evaluating CYB003 for adjunctive treatment of Major Depressive Disorder. The program aims to enroll approximately 550 patients across 40+ clinical sites in the US and Europe. Segal Trials serves as the first program member and strategic partner in this pivotal psychedelic research initiative.
- Compass Health SystemscorePrivate practice affiliation with Compass Health Systems, the largest behavioral healthcare practice in South Florida, providing access to specialized patient populations and helping meet enrollment goals.
- Larkin Behavioral Health ServicescorePartnership for inpatient and early phase clinical research services at 1201 North 37th Ave, Hollywood, FL, expanding Segal Trials' capacity for complex psychiatric studies.
- AbbViecorePharmaceutical sponsor partnership for conducting clinical trials. AbbVie is one of many major pharmaceutical companies Segal Trials partners with for drug development research.
- RochecorePharmaceutical sponsor partnership for conducting clinical trials as part of Segal Trials' work with international medical leaders.
- TevacorePharmaceutical sponsor partnership for conducting clinical trials.
- Johnson & JohnsoncorePharmaceutical sponsor partnership for conducting clinical trials as one of the international medical leaders Segal Trials collaborates with.
- PfizercorePharmaceutical sponsor partnership for conducting clinical trials.
- JanssencorePharmaceutical sponsor partnership for conducting clinical trials.
- IQVIAcoreCRO partnership for clinical trial management and coordination services.
- SyneoscoreCRO partnership for clinical trial management and coordination services.
- Boehringer IngelheimcorePharmaceutical sponsor partnership for conducting clinical trials.
- UsonacorePharmaceutical sponsor partnership specifically for psychedelic research studies.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Segal Trials competitors and assessment
Company assessmentDirect peers
- Flourish Research: Clinical research site network running Phase I-IV trials across diverse indications, comparable in size and multi-therapeutic breadth to Segal Trials.
- Velocity Clinical Research: Large multi-therapeutic clinical research site network operating across the US; directly comparable business model (multi-site SMO) competing for the same pharmaceutical and CRO sponsors as Segal Trials.
- CenExel: Network of clinical research sites with strong early-phase and CNS expertise; competes with Segal for Phase I-IV psychiatric, neurology, and addiction trials from the same sponsor base.
- ClinEdge: Clinical research site services organization with multi-therapeutic trial execution and patient recruitment capabilities similar to Segal's model.
- Elligo Health Research: Clinical research site network leveraging technology-enabled patient access; operates a comparable SMO model competing for sponsors seeking rapid enrollment.
- Wake Research: Multi-site clinical research organization offering Phase I-IV trials across multiple therapeutic areas; directly comparable SMO model with similar sponsor relationships.
- WCCT Global: Early-phase clinical research site organization with strong Phase I and CNS capabilities; directly comparable in inpatient/early-phase capacity and therapeutic focus.
Broad incumbents
- ICON plc: Global CRO (including legacy PRA Health Sciences) offering comprehensive clinical development services; competes for the same pharmaceutical sponsors and occasionally provides site network solutions.
- Medpace: Mid-to-large CRO offering full-service clinical development including site services; overlaps with Segal as both a potential CRO partner and indirect competitor for sponsor contracts.
- IQVIA: Largest global CRO and life sciences services firm; listed as a Segal partner but also a broad incumbent whose site services and technology offerings overlap with Segal's value proposition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Segal Trials social profiles
Digital presenceSegal Trials compliance and trust
Trust signalCompliance4 records
Segal Trials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Segal Trials leadership team
Management profileNumber of profiles
Profiles9 records
Segal Trials funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Segal Trials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Segal Trials
What does Segal Trials do?
Segal Trials operates a private network of clinical research sites across South Florida conducting Phase I-IV clinical trials for pharmaceutical sponsors and CROs. The company specializes in psychiatry, neurology, addiction, general medicine, infectious diseases, psychedelics research, and women's health, providing patient recruitment, data collection, quality assurance, and regulatory compliance services under contract with drug developers.
Is Segal Trials a public or private company?
Segal Trials is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Segal Trials founded?
Segal Trials was founded in 1998. It employs 101 to 250 people.
Where is Segal Trials based?
Segal Trials is headquartered in Miami Lakes, United States, in the North America region.
How does Segal Trials make money?
One revenue line is on record: clinical Trial Services.
Who are Segal Trials's main competitors?
Direct peers on record are Flourish Research, Velocity Clinical Research, CenExel, ClinEdge, Elligo Health Research, Wake Research and WCCT Global. Broad incumbents are ICON plc, Medpace and IQVIA.
Does Segal Trials have an API?
No public API is recorded for Segal Trials.
What industry is Segal Trials in?
Segal Trials's product category is Contract Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAIALAE, Clinical Development (Phase I–III Trial Design & Execution). Its NAICS code is 6215 and its SIC code is 8071.